Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5606
Source ID: NCT06797115
Associated Drug: Sglt-2 Inhibitor
Title: Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: T2DM
Interventions: DRUG: SGLT-2 inhibitor
Outcome Measures: Primary: CPT, current perception thresholds (CPT) at three frequencies (2000 Hz, 250 Hz, and 5 Hz) on both median and peroneal nerve, providing insight into large myelinated (2000Hz Aβ), medium-size myelinated (250Hz Aδ) and unmyelinated (5Hz C) small fibers function, baseline and week 4 | Secondary: Fructosamine, baseline and week 4|Fasting plasma glucose, baseline and week 4|BMI, body-mass index, baseline and week 4|SBP (standing), systolic blood pressure at standing position, baseline and week 4|eGFR, estimated glomerular flitration rate, baseline and week 4|MAU, urinary albumine concentration, baseline and week 4|RBC, red blood cell count, baseline and week 4|Hgb, hemoglobin, baseline and week 4|Htc, hematocrit, baseline and week 4|PLT, platelet count, baseline and week 4|Serum (m-Tyr+o-Tyr)/p-Tyr, Serum (meta-tyrosine + ortho-tyrosine)/para-tyrosine ratio, baseline and week 4|Urinary (m-Tyr+o-Tyr)/p-Tyr, Urinary (meta-tyrosine + ortho-tyrosine)/para-tyrosine ratio, baseline and week 4|Serum o-Tyr, Serum concentration of ortho-tyrosine, baseline and week 4|Serum o-Tyr/Phe, Serum ortho-tyrosine/phenilalanine ratio, baseline and week 4|Serum o-Tyr/p-Tyr, Serum ortho-tyrosine/para-tyrosine ratio, baseline and week 4
Sponsor/Collaborators: Sponsor: University of Pecs
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 40
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2022-07-18
Completion Date: 2024-06-30
Results First Posted:
Last Update Posted: 2025-01-28
Locations: 2nd Department of Medicine and Nephrology-Diabetes Center, University of Pécs Medical School, Pécs, Baranya, H-7624, Hungary
URL: https://clinicaltrials.gov/show/NCT06797115